Key result
Circulating Ang-2 and sTie-2 were higher in metabolic syndrome and showed heritability of 27% and 56%, with sTie-2 linked to chromosome 9.
Why the study?
What are the clinical correlates, heritability, and genetic linkage loci of circulating angiopoietin-2 (Ang-2) and soluble Tie-2 (sTie-2) in a large community-based adult population?
Cross-Sectional (n=3,778)
No
What are the clinical correlates, heritability, and genetic linkage loci of circulating angiopoietin-2 (Ang-2) and soluble Tie-2 (sTie-2) in a large community-based adult population?
Answers are grounded in this paper and cite their sources.
This community-based study demonstrates that circulating endothelial growth factors Ang-2 and sTie-2 are heritable traits strongly associated with distinct components of the metabolic syndrome and cardiovascular risk factors, linking genetic and metabolic pathways to vascular remodeling.
BACKGROUND: Experimental studies suggest that endothelial growth factors play an important role in angiogenesis and vascular remodeling. The clinical and genetic correlates of circulating angiopoietin-2 (Ang-2) and its soluble receptor/regulator Tie-2 (sTie-2) have not been determined in a community-based sample. METHODS AND RESULTS: Serum Ang-2 and sTie-2 were assayed in 3778 third-generation cohort participants of the Framingham Heart Study (mean age, 40+/-9 years; 53% women). Clinical correlates and heritability of both biomarkers were assessed using generalized estimating equations and variance-component analyses. Ang-2 levels were higher and sTie-2 levels were lower in women than in men. Ang-2 was positively related to age, smoking, systolic blood pressure, hypertension treatment, and diabetes (P<0.05 for all) but was inversely associated with total cholesterol and diastolic blood pressure (P<0.0001 for both), and sTie-2 was positively associated with body mass index, diabetes, and triglycerides but was inversely related to age, alcohol consumption, and glomerular filtration rate (P<0.05 for all). Both Ang-2 and sTie-2 were higher in participants with metabolic syndrome (P<0.005), with stronger associations of Ang-2 with blood pressure traits and of sTie-2 with obesity-dyslipidemia components. Heritability estimates for Ang-2 and sTie-2 were 27% and 56%, respectively (P<0.0001). A region on chromosome 9 was significantly linked to circulating sTie-2 levels (logarithm of the odds score, 8.31). CONCLUSION: Circulating levels of Ang-2 and sTie-2 are heritable traits associated with cardiovascular disease risk factors, including the metabolic syndrome. These observations are consistent with the notion that angiogenesis and vascular remodeling are determined in part by genetic influences and associated with metabolic risk factors.
No takes yet. Share an insight, caveat, or question.
Lieb et al. (2010) conducted a cross-sectional in Community-based adults free of prevalent cardiovascular disease evaluated for cardiovascular and metabolic risk factors (n=3,778). Circulating serum Angiopoietin-2 (Ang-2) and soluble Tie-2 (sTie-2) concentrations and traditional cardiovascular/metabolic risk factors was evaluated on Clinical correlates (including metabolic syndrome and ECG-determined left ventricular hypertrophy) and heritability/genetic linkage of circulating Ang-2 and sTie-2 (OR 1.02, 95% CI 1.01-1.04, p=0.011). Circulating Ang-2 and sTie-2 were higher in metabolic syndrome and showed heritability of 27% and 56%, with sTie-2 linked to chromosome 9.
Synapse has enriched 10 related papers. Consider them for comparative context: